MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

488325

Report Date :

27.01.2018

 

IDENTIFICATION DETAILS

 

Name :

ZENZI PHARMACEUTICAL INDUSTRIES PRIVATE LIMITED (w.e.f. 27.11.2016)

 

 

Formerly Known As :

ALPHA PHARMA HEALTHCARE INDIA PRIVATE LIMITED

 

 

Registered Office :

B-205, Universal Business Park Off Saki Vihar Road, Chandivali, Mumbai – 400072, Maharashtra

Tel. No.:

91-22-42911000 / 42911021

 

 

Country :

India

 

 

Financials (as on) :

31.03.2016

 

 

Date of Incorporation :

20.12.2005

 

 

Com. Reg. No.:

11-234083

 

 

Capital Investment / Paid-up Capital :

INR 850.258 Million

 

 

CIN No.:

[Company Identification No.]

U24231MH2005PTC234083

 

 

IEC No.:

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAMCA3683N

 

 

GSTIN :

27AAMCA3683N1Z0

 

 

Legal Form :

Private Limited Liability Company.

 

 

Line of Business :

Manufacture of Allopathic Pharmaceutical Preparations. (Registered activity)

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

B

 

Credit Rating

Explanation

Rating Comments

B

Medium Risk

Business dealings permissible on a regular monitoring basis

 

Maximum Credit Limit :

USD 2800000

 

 

Status :

Moderate 

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a wholly owned subsidiary “Alpha Pharma Group Limited”, Seychelles. The company was incorporated in the year 2005.

 

It is a manufacturer of Chemical.

 

Management has failed to file its financials with Registrar of Companies for the FY 2017.

 

As per the available financial of 2016, the revenue of the company has decreased by 45.72% and has incurred operational loss.

 

The moderate financial profile of the company is marked by low reserve base as compared to its capital.

 

Rating is constrained on account of absence of latest financials.

 

However, rating weakness is partially offset by strong debt coverage indicators due to debt free balance sheet profile.

 

Rating takes into consideration equity infused by its promoters.

 

Rating also takes into account of strong financial and managerial support that company receives from its holding entity backed by its well experienced management team.

 

Business is active. Payments are reported to be slow but correct.

 

In view of aforesaid, the company can be considered for business dealings with some caution.

 

Note: The Company has changed its name from “Alpha Pharma Healthcare India Private Limited” to Zenzi Pharmaceutical Industries Private Limited” w.e.f. 27 November, 2016.

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.06.2017)

Current Rating

(30.09.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 27.01.2018

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Sherly Justine

Designation :

Director

Contact No.:

91-9004116618

Date :

25.01.2018

 

91-22-42911000 (Ringing)

 

 

LOCATIONS

 

Registered Office :

B-205, Universal Business Park Off Saki Vihar Road, Chandivali, Mumbai – 400072, Maharashtra, India

Tel. No.:

91-22-42911000 / 42911021

Mobile No.:

91-9004116618 (Mr. Sherly Justine)

Fax No.:

91-22-42911001

E-Mail :

jsf@alpha-pharma.co

info@alpha-pharma.com

sj@alpha-pharma.com 

Website :

www.alpha-pharma.com

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Jacob Sporon Fiedler

Designation :

Director

Address :

3103, A and B, 31st Floor, Avalon, Hiranandani Gardens, A. S. Marg, Powai, Mumbai – 400076, Maharashtra, India

Date of Birth/Age :

22.08.1981

Qualification :

B.Com

Date of Appointment :

20.12.2005

PAN No.:

BLUPS0359A

DIN No.:

01660842

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24110MH1970PLC014768

MEGHDOOT CHEMICALS LIMITED

03/01/2018

-

U51909DL2010FTC198694

MOIRAE GENERICS PRIVATE LIMITED

04/02/2010

-

U24232MH2011FTC241859

DUNE MEDICARE PRIVATE LIMITED

23/05/2011

-

U24232MH2012PTC232068

COIN PHARMACEUTICALS PRIVATE LIMITED

19/08/2013

-

U74999MH2014FTC252081

ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED

15/01/2014

-

U24297MH2013FTC239278

UNIGEN LIFE SCIENCES PRIVATE LIMITED

04/01/2013

-

 

 

Name :

Mr. Sherly Justine

Designation :

Director

Address :

Flat No H-401, 4th Floor, Yash Paradise, Plot No 4,5,6,7, Sector No 8-A, Airoli, Navi Mumbai – 400708, Maharashtra, India

Date of Birth/Age :

01.02.1969

Qualification :

M.Com

Date of Appointment :

26.07.2011

PAN No.:

AJFPJ2854D

DIN No.:

03477901

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24110MH1970PLC014768

MEGHDOOT CHEMICALS LIMITED

03/01/2018

-

U24232MH2011FTC241859

DUNE MEDICARE PRIVATE LIMITED

23/05/2011

-

U24232MH2012PTC232068

COIN PHARMACEUTICALS PRIVATE LIMITED

07/01/2013

-

U74999MH2014FTC252081

ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED

15/01/2014

-

U24297MH2013FTC239278

UNIGEN LIFE SCIENCES PRIVATE LIMITED

04/01/2013

-

 

 

KEY EXECUTIVES

 

Name :

Mr. Jayesh Chandrakant Awati

Designation :

Company Secretary

Address :

Babaji Chawl, Ram Mandir, Veer Kotwal Chowk, Kala Talao, Kalyan (West), Kalyan – 421301, Maharashtra, India

Date of Appointment :

09.12.2013

PAN No.:

AUDPA7536Q

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.03.2016

 

Names of Shareholders

 

No. of Shares

Alpha – Pharma Group Limited (Including the nominee shares held by Jacob Sporon-fiedler)

 

85025780

 

 

 

Total

 

85025780

 

As on 15.04.2016

 

Names of Allotees

 

No. of Shares

Alpha – Pharma Group Limited

 

7316125

 

 

 

Total

 

7316125

 

As on 07.07.2016

 

Names of Allotees

 

No. of Shares

Alpha – Pharma Group Limited

 

7058250

 

 

 

Total

 

7058250

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 26.09.2016

 

Category

Percentage

Promoter – (Individual/ Hindu Undivided Family – Non-residential Indian)

0.08

Promoter - Bodies corporate

99.92

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacture of Allopathic Pharmaceutical Preparations. (Registered activity)

 

 

Products :

Item Code No.

Product Description

98041000

Alphabol Tablets, Boldebolin, Induject, Nandrorapid

 

NIC Code No.

Product Description

21002

Manufacture of allopathic pharmaceutical preparations

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

PRODUCTION STATUS NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Information declined by the management

 

 

Bankers :

Bank Name

Kotak Mahindra Bank Limited

Branch

Tembhi Naka Branch, Ground Floor and Mezzanine Floor, Shop No. 4,5,6,7, Mayurpankh, Thane – 400601, Maharashtra, India

Person Name (With Designation)

--

Contact Number

91-22-67594849 (Ringing)

Name of Account Holder

--

Account Number

0111520879

Account Since (Date/Year of Account Opening)

--

Average Balance Maintained (If Possible)

--

Credit Facilities Enjoyed (If any)

--

Account Operation

--

Remarks (If any)

--

 

Auditors :

 

Name :

Borkar Girish Manohar

Chartered Accountants

Address :

Shubham, A-1012, Corporate Avenue, Sonawala Road, Goregaon (East), Mumbai – 400063, Maharashtra, India

Tel No.:

91-22-28391147 / 53

Email.:

girish@borkarnshenoy.in

client.info@borkarnsheny.in

Website :

www.borkarnshenoy.in

PAN N Income-tax PAN of auditor or auditor's firm :

AADFB6915E

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Holding Company :

Alpha Pharma Group Limited, Seychelles

 

 

Other Related Parties :

  • Moirae Generics Private Limited
  • Unigen Life Sciences India Private Limited

 

 

CAPITAL STRUCTURE

 

After 26.09.2016

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

105000000

Equity Shares

INR 10/- each

INR 1050.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

85025780

Equity Shares

INR 10/- each

INR 850.258 Million

 

 

As on 31.03.2016

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

100000000

Equity Shares

INR 10/- each

INR 1000.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

58982475

Equity Shares

INR 10/- each

INR 589.825 Million

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2016

31.03.2015

31.03.2014

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

850.258

589.825

356.189

(b) Reserves and Surplus

62.713

78.123

49.596

(c) Money received against share warrants

0.000

0.000

0.000

(d) Minority interest

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

54.386

10.867

41.995

Total Shareholders’ Funds (1) + (2)

967.357

678.815

447.780

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long-term liabilities

1.395

3.165

9.763

(d) long-term provisions

33.878

33.878

21.877

Total Non-current Liabilities (3)

35.273

37.043

31.640

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

0.000

0.000

0.000

(b) Trade payables

78.986

64.109

67.448

(c) Other current liabilities

97.617

40.312

5.530

(d) Short-term provisions

5.688

11.744

1.726

Total Current Liabilities (4)

182.291

116.165

74.704

 

 

 

 

TOTAL

1184.921

832.023

554.124

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

358.333

81.522

62.122

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Tangible assets capital work-in-progress

694.361

632.892

393.107

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

4.702

14.218

3.950

(d) Long-term loans and advances

53.926

37.836

26.692

(e) Other Non-current assets

3.156

0.816

8.516

Total Non-Current Assets

1114.478

767.284

494.387

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

25.672

10.154

46.108

(c) Trade receivables

0.000

5.464

0.561

(d) Cash and bank balances

19.489

8.127

11.756

(e) Short-term loans and advances

25.180

40.954

1.312

(f) Other current assets

0.102

0.040

0.000

Total Current Assets

70.443

64.739

59.737

 

 

 

 

TOTAL

1184.921

832.023

554.124

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2016

31.03.2015

31.03.2014

 

SALES

 

 

 

 

Total Revenue from operations

233.355

429.915

419.750

 

Other Income

1.228

1.221

9.003

 

TOTAL

234.583

431.136

428.753

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

140.418

297.430

325.436

 

Employee benefit expense

21.072

20.602

12.009

 

Other expenses

64.948

67.815

46.466

 

Exceptional items before tax

0.000

1.480

0.000

 

TOTAL

226.438

387.327

383.911

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

8.145

43.809

44.842

 

 

 

 

 

Less

FINANCIAL EXPENSES

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

8.145

43.809

44.842

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

14.040

13.549

4.524

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

(5.895)

30.260

40.318

 

 

 

 

 

Less

TAX

9.515

1.733

13.557

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

(15.410)

28.527

26.761

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

226.994

423.135

0.000

 

TOTAL EARNINGS

226.994

423.135

0.000

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

(0.181)

0.484

0.454

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2016

31.03.2015

31.03.2014

Current Maturities of Long term debt

NA

NA

NA

Net cash flows from (used in) operations

69.476

74.205

126.357

Net cash flows from (used in) operating activities

59.960

66.083

117.452

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

 

31.03.2016

31.03.2015

31.03.2014

Average Collection Days

[Sundry Debtors / Income * 365]

 

0.00

4.64

0.49

 

 

 

 

 

Account Receivables Turnover

[Income / Sunday Debtors]

 

0.00

78.68

748.22

 

 

 

 

 

Average Payment Days [Sundry Creditors / Purchases * 365]

 

205.31

78.67

75.65

 

 

 

 

 

Inventory Turnover [Operating Income / Inventories]

 

0.32

4.31

0.97

 

 

 

 

 

Asset Turnover [Operating Income / Net Fixed Assets]

 

0.01

0.06

0.10

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

 

31.03.2016

31.03.2015

31.03.2014

Debt Ratio [(Borrowing + Current Liabilities) / Total Assets]

 

0.15

0.14

0.13

 

 

 

 

 

Debt Equity Ratio (Borrowings / NetWorth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Liabilities to Networth (Current Liabilities / NetWorth)

 

0.19

0.17

0.17

 

 

 

 

 

Fixed Assets to NetWorth (Net Fixed Assets / NetWorth)

 

1.09

1.05

1.02

 

 

 

 

 

Interest Coverage Ratio [PBIT / Financial Charges]

 

0.00

0.00

0.00

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2016

31.03.2015

31.03.2014

Net Profit Margin [(PAT / Sales) * 100]

(%)

(6.60)

6.64

6.38

 

 

 

 

 

Return on Total Assets [(PAT / Total Assets) * 100]

(%)

(1.30)

3.43

4.83

 

 

 

 

 

Return on Investment (ROI) [(PAT / NetWorth) * 100]

(%)

(1.59)

4.20

5.98

 

 

SOLVENCY RATIO

 

PARTICULARS

 

 

31.03.2016

31.03.2015

31.03.2014

Current Ratio [Current Assets / Current Liabilities]

 

0.39

0.56

0.80

 

 

 

 

 

Quick Ratio [(Current Assets - Inventories) / Current Liabilities]

 

0.25

0.47

0.18

 

 

 

 

 

G-Score Ratio Financial [NetWorth / Total Assets]

 

0.82

0.82

0.81

 

 

 

 

 

G-Score Ratio Debt [Debts / Equity Capital]

 

0.00

0.00

0.00

 

 

 

 

 

G-Score Ratio Liquidity [Total Current Assets / Total Current Liabilities]

 

0.39

0.56

0.80

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2014

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

356.189

589.825

850.258

Reserves & Surplus

49.596

78.123

62.713

Share Application money pending allotment

41.995

10.867

54.386

Net worth

447.780

678.815

967.357

 

 

 

 

Long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2014

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

419.750

429.915

233.355

 

 

2.422

(45.721)

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2014

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

419.750

429.915

233.355

Profit/ (Loss)

26.761

28.527

(15.410)

 

6.38 %

6.64 %

(6.60 %)

 

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

No

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

No

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 


 

 

INDEX OF CHARGES: NO CHARGES EXIST FOR THE COMPANY

 

 

 

FIXED ASSETS

 

  • Land
  • Buildings
  • Plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Office equipment
  • Computer equipments

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 63.64

UK Pound

1

INR 89.32

Euro

1

INR 78.45

 

 

INFORMATION DETAILS

 

Information Gathered by :

SUP

 

 

Analysis Done by :

VAR

 

 

Report Prepared by :

KJL


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.